September 30, 2023
Brain cancer and immunotherapy treatment
Research led by Catherine Flores may move into clinical testing within 18 months.

Cancer Care

Brain cancer and immunotherapy treatment

Amy Martinez | 1/25/2019

One cancer that hasn’t responded well to immunotherapy is brain cancer. Glioblastoma, the most common type of adult brain cancer, remains especially difficult to treat — and deadly. Patients with a glioblastoma tumor typically die within two years of being diagnosed.

Now, researchers at the University of Florida say they’ve made a discovery that could lead to an effective immunotherapy for brain cancer.

Their research focuses on a class of immunotherapy drugs called immune checkpoint inhibitors, which can unleash a patient’s immune system against cancer by blocking proteins that suppress the body’s ability to destroy cancer cells. So far, the drugs generally have not worked on malignant brain tumors.

In an article recently published in the journal Nature Communications, Catherine Flores, an assistant professor in the UF College of Medicine’s neurosurgery department, describes how stem cells from bone marrow could be used to reprogram glioblastoma tumors to make them responsive to checkpoint inhibitors. She and her team at UF hope to move their research into clinical testing during the next 12 to 18 months.

“This is truly one of the more exciting developments I’ve seen in our field in many years,” says Dr. Duane Mitchell, co-director of the Center for Brain Tumor Therapy at UF. If clinical trials bear out Flores’ findings, he says, it would bring new hope to “patients who do not currently benefit from this remarkable class of immunotherapeutic treatment.”


Read more in our February issue.

Select from the following options:


Access Article Now!


Get a single DIGITAL copy of this issue



Get a single PRINT copy of this issue

plus $3 postage & handling


One year in PRINT

plus a FREE gift!


One year DIGITAL

plus a FREE gift!


One year Combo

plus a FREE gift!


If you are already a print subscriber,
to your existing subscription here!
(or call our office at 727-892-2643)

* offer valid for new subscribers only

Tags: Healthcare, Life Sciences, Economic Backbone, Feature

Florida Business News

  • Florida’s population boom drives bigger hurricane losses, despite tougher building codes

    Florida leads the nation in strict building codes, and the decades of hard work have paid off in the increasing number of homes and buildings that survive each time a hurricane slashes the state. But all those hard-won gains have been undermined by the explosion of growth along the coast.

  • Business BeatBusiness Beat - Week of September 29th

    Get top news-to-know with Florida Trend's headline-focused video news brief, hosted by digital content specialist Aimée Alexander.

  • Enterprise Florida exiting

    The doors are ready to close on Enterprise Florida, the business-recruitment agency long targeted by state House leaders.

  • Seeking protection

    Three activist groups served notice to the U.S. Fish and Wildlife Service that they intend to sue to force the agency to invoke Endangered Species Act protection for the ghost orchid.

  • State jobless claims decrease

    An estimated 5,155 first-time jobless claims were filed in Florida last week, a decrease from the previous week and below the average for the year.

Florida News Releases

Florida Trend Video Pick

Radioactive roads? Florida has yet to submit application to EPA to start testing
Radioactive roads? Florida has yet to submit application to EPA to start testing

It appears no steps have been taken to begin testing whether slightly radioactive waste from fertilizer production can be repurposed for Florida road construction projects.

Video Picks | Viewpoints@FloridaTrend

Ballot Box

Do you believe that home values in Florida have finally peaked?

  • Absolutely!
  • No way!
  • The jury's still out...
  • Other (Let us know in the comment section below)

See Results

Florida Trend Media Company
490 1st Ave S
St Petersburg, FL 33701

© Copyright 2023 Trend Magazines Inc. All rights reserved.